Literature DB >> 1405822

Diagnosis, treatment, and prevention of malaria.

S L Hoffman1.   

Abstract

Optimal treatment of malaria requires rapid case identification, initiation of specific and supportive therapy based on parasitologic and clinical classification of the patient, and recognition of inadequate response to therapy. Health care providers advising travelers should assess the risk of malaria based on itinerary and clinical condition, and counsel to reduce contact with mosquitoes; prescribe appropriate chemoprophylaxis; and counsel regarding potential side effects and requirement for diagnosis and treatment if fever develops.

Entities:  

Mesh:

Year:  1992        PMID: 1405822     DOI: 10.1016/s0025-7125(16)30290-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

1.  Therapy and drug resistance in malaria.

Authors:  A V Kulkarni; L Kasturi; A Amin; V Mashankar
Journal:  Indian J Pediatr       Date:  2000-01       Impact factor: 1.967

2.  Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects.

Authors:  Peter E Nasveld; Michael D Edstein; Mark Reid; Leonard Brennan; Ivor E Harris; Scott J Kitchener; Peter A Leggat; Philip Pickford; Caron Kerr; Colin Ohrt; William Prescott
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

3.  Interleukin 12 induction of interferon gamma-dependent protection against malaria.

Authors:  M Sedegah; F Finkelman; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

4.  Chemotherapy of drug-resistant malaria.

Authors:  K C Kain
Journal:  Can J Infect Dis       Date:  1996-01

Review 5.  Drugs for treating uncomplicated malaria in pregnant women.

Authors:  Lois C Orton; Aika A A Omari
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 6.  Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.

Authors:  L B Barradell; A Fitton
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

7.  Imported tertian malaria resistant to primaquine.

Authors:  D J Na; J D Han; D Y Cha; I K Song; H W Choi; E A Chung; C W Park; J S Choi
Journal:  Korean J Intern Med       Date:  1999-07       Impact factor: 2.884

8.  An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community.

Authors:  Theodora A Okeke; Benjamin S C Uzochukwu; Henrietta U Okafor
Journal:  Malar J       Date:  2006-11-01       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.